Tirzepatide – 20MG

Dual GLP-1 / GIP Receptor Agonist (Research Compound)

Dual GLP-1 / GIP receptor agonists are selected for advanced laboratory investigation into incretin receptor signaling and metabolic regulatory pathways. These compounds are commonly studied in controlled research models evaluating appetite-related signaling mechanisms, glucose metabolism pathways, and energy utilization processes.

Within structured environments, researchers examine receptor activity, insulin-associated signaling dynamics, and broader metabolic efficiency markers. Ongoing scientific evaluation continues to explore the role of dual incretin receptor modulation in metabolic research frameworks.

For research use only. Not for human consumption.
This product is not approved by the U.S. Food and Drug Administration and is supplied strictly for laboratory, educational, and research purposes.